Glenmark Pharmaceuticals has received final USFDA approval for its generic version of BenzaClin gel used in the treatment of acne. The ointment gel Clindamycin and Benzoyl Peroxide Gel, 1 per cent|5 per cent, is a generic version of BenzaClin1 Gel, 1 per cent/ 5 per cent, of Valeant Bermuda. According to market estimates, BenzaClin Gel, 1 per cent/ 5 per cent had sales of $99.4 million in the 12-month period ended January 2019.
Company Profile : Glenmark Pharma Ltd
Leave a Reply